The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced its intention to introduce sweeping reforms for accelerating rare disease therapy development and approval, with the aim ...
Beijing’s latest rare earth restrictions, intended to consolidate an already dominant position and boost its leverage amid ongoing trade negotiations, may be an ill-judged gambit that could see China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results